POPARTS: Post-Operative Pain After Recovery in Thoracic Surgery

Sponsor
University of Trieste (Other)
Overall Status
Unknown status
CT.gov ID
NCT04300660
Collaborator
(none)
250
1
29.2
8.6

Study Details

Study Description

Brief Summary

Persistent pain after surgery has significant physical and mental consequences for the patient, as well as a significant economic impact on health systems. Neuropathic pain is caused by direct or indirect damage to the somatosensitive system. In thoracic surgery, chronic neuropathic pain is represented by Post-Thoracotomic Pain Syndrome (PTPS), defined as recurrent or persistent pain in the thoracotomy scar site that persists for more than 3-6 months. Currently, in literature, the prevalence of PTPS is extremely variable. This prospective observational study aims to assess the incidence of pain in the weeks and months following surgery and to assess whether and how the presence of painful symptoms changes the patient's quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: neuropathic pain after thoracic surgery

Detailed Description

For each patient enrolled in the study, in the pre-operative phase, comorbidities, any chronic analgesic therapy and quality of life (through a dedicated questionnaire - Euro QoL 5D5L1) will be recorded. Surgical data (type of procedure, lobe affected by resection, type of approach and surgical time) and anesthesiological data (intravenous opioid, locoregional technique (s), non-opioid analgesics administered and other medications) will be collected in the perioperative phase. In the 48 hours following the surgery (in the Recovery Room, at 6h, 12h, 24h, 36h and 48h) the patient's pain data will be recorded (static, dynamic and cough-associated NRS) and those relating to any complications. The total amount of morphine administered to the patient in the first 48 hours will also be recorded. Each patient will be evaluated 7 days, 1, 3 and 6 months after the surgery by telephone interview. In this last phase, the possible presence of pain and its characteristics will be assessed, especially if these meet the criteria of neuropathic pain.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
250 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
POPARTS Study- Post-Operative Pain After Recovery in Thoracic Surgery: Evaluation of the Persistence of Painful Symptoms and the Incidence of Neuropathic Pain After Resective Lung Surgery
Actual Study Start Date :
Oct 25, 2017
Anticipated Primary Completion Date :
Apr 1, 2020
Anticipated Study Completion Date :
Apr 1, 2020

Outcome Measures

Primary Outcome Measures

  1. Incidence of persistent post-operative pain after thoracic surgery [the data needed to analyze the incidence and characteristics of pain will be collected at 1 week after surgery]

    The incidence of static, dynamic and cough-associated pain is assessed through the numerical rate scale (NRS), by a telephone interview one week and one month after surgery. A questionnaire is submitted to the patient to analyze the characteristics of the pain and its possible impact on the patient's quality of life.

  2. Incidence of persistent post-operative pain after thoracic surgery [the data needed to analyze the incidence and characteristics of pain will be collected at 1 month after surgery]

    The incidence of static, dynamic and cough-associated pain is assessed through the numerical rate scale (NRS), by a telephone interview one week and one month after surgery. A questionnaire is submitted to the patient to analyze the characteristics of the pain and its possible impact on the patient's quality of life.

  3. Incidence of Chronic Pain after thoracic surgery [The data needed to analyze the presence of chronic pain will be collected at 3 months after surgery]

    The possible presence and incidence of chronic pain is assessed through a telephone interview three and six months after surgery.

  4. Incidence of Chronic Pain after thoracic surgery [The data needed to analyze the presence of chronic pain will be collected at 6 months after surgery]

    The possible presence and incidence of chronic pain is assessed through a telephone interview three and six months after surgery.

  5. Presence of pain with typical features of neuropathic pain in the different phases of the postoperative course [The data neede to analyze the presence of neuropathic pain will be collected at a week after the surgery]

    During each telephone interview the presence of neuropathic pain is assessed through a dedicated questionnaire (PainDetect Questionnaire) and the impact that this type of pain has on the patient's quality of life.

  6. Presence of pain with typical features of neuropathic pain in the different phases of the postoperative course [The data neede to analyze the presence of neuropathic pain will be collected at a month after the surgery]

    During each telephone interview the presence of neuropathic pain is assessed through a dedicated questionnaire (PainDetect Questionnaire) and the impact that this type of pain has on the patient's quality of life.

  7. Presence of pain with typical features of neuropathic pain in the different phases of the postoperative course [The data neede to analyze the presence of neuropathic pain will be collected at 3 months after the surgery]

    During each telephone interview the presence of neuropathic pain is assessed through a dedicated questionnaire (PainDetect Questionnaire) and the impact that this type of pain has on the patient's quality of life.

  8. Presence of pain with typical features of neuropathic pain in the different phases of the postoperative course [The data neede to analyze the presence of neuropathic pain will be collected at 6 months after the surgery]

    During each telephone interview the presence of neuropathic pain is assessed through a dedicated questionnaire (PainDetect Questionnaire) and the impact that this type of pain has on the patient's quality of life.

Secondary Outcome Measures

  1. Assessment of the incidence of chronic pain based on the different surgical techniques in thoracic surgery [during the intraoperative phase, data relating to the surgical techniques performed are collected]

    the aim of this objective is to analyze whether different surgical techniques (more or less invasive) play a role in the onset of chronic pain after thoracic surgery

  2. Assessment of the post-operative quality of life based on the different surgical techniques in thoracic surgery [during the intraoperative phase, data relating to the surgical techniques performed are collected]

    the aim of this objective is to analyze whether different surgical techniques (more or less invasive) play a role in the quality of life after thoracic surgery

  3. Evaluation of postoperative pain control based on different anesthesiological techniques and its possible correlation with the development of chronic pain [data relating to this objective are collected in the intraoperative, 24 hours after surgery and subsequent telephone interviews at 1 week, 1, 3 and 6 months after thoracic surgery]

    the aim of this objective is to analyze whether different anesthesiological techniques play a role in the onset of chronic or neuropathic pain after thoracic surgery. The techniques of locoregional anesthesia performed and the drugs used both during surgery and in the postoperative phase are analyzed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Patient's consent to the trial

  • Candidate to resective lung surgery (lobectomy, segmentectomy, atypical resection) with minimally invasive approach (mini-thoracotomy with muscle sparing or video-assisted thoracic surgery, VATS)

Exclusion Criteria:
  • neurological and / or cognitive deficits

  • inability to obtain informed consent

  • surgeries that include wall resections (pleural, muscle, rib or nerve)

  • pneumonectomy

  • Previous thoracic surgery at the time of enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cattinara Hospital Trieste Italy 34149

Sponsors and Collaborators

  • University of Trieste

Investigators

  • Study Director: Umberto Lucangelo, MD PhD, University of Trieste
  • Principal Investigator: Marzia Umari, MD, University of Trieste

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marzia Umari, Principal Investigator, University of Trieste
ClinicalTrials.gov Identifier:
NCT04300660
Other Study ID Numbers:
  • N. ASUI TS 8/2017
First Posted:
Mar 9, 2020
Last Update Posted:
Mar 9, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marzia Umari, Principal Investigator, University of Trieste
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2020